Evaluation of 42 cytokines, chemokines and growth factors for prediction of cardiovascular outcome in patients with coronary artery disease

Int J Cardiol. 2015 Apr 1:184:724-727. doi: 10.1016/j.ijcard.2015.03.035. Epub 2015 Mar 4.

Affiliations

¹ Erasmus MC, Department of Cardiology, Rotterdam, the Netherlands.
² UMR3145 CNRS Bio-Rad, Sysdiag Laboratory, Montpellier, France.
³ Inserm U698, Bichat Hospital, Paris, France and CHU de la Reunion, Saint-Denis, La Reunion, France; CHU de la Reunion, Saint-Denis, La Reunion, France.
⁴ Erasmus MC, Department of Cardiology, Rotterdam, the Netherlands. Electronic address: i.kardys@erasmusmc.nl.

PMID: 25795084
DOI: 10.1016/j.ijcard.2015.03.035

No abstract available

Keywords: Biomarkers; Chemokines; Coronary artery disease; Cytokines; Prognosis.

Publication types

Evaluation Study
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Chemokines / blood*
Coronary Artery Disease / blood*
Coronary Artery Disease / diagnosis*
Coronary Artery Disease / therapy
Cytokines / blood*
Female
Follow-Up Studies
Humans
Intercellular Signaling Peptides and Proteins / blood*
Male
Middle Aged
Predictive Value of Tests
Prospective Studies
Treatment Outcome

Substances

Chemokines
Cytokines
Intercellular Signaling Peptides and Proteins